You are using the account as a guest user. You can also place your order directly without signning in or signing up.
Get them delivered to your doorstep with Upto 10% OFF on all your pharmacy orders!
You can book lab tests for yourself and your family with Healthwire and avail Upto 28% OFF on lab tests from top labs!
Elevate your business with our Pharmacy Franchising Model and Earn 40% Annual Return On Investment.
by Naba Batool
This gap was the reason that WHO declared a moratorium on the availability of booster shots in economically stable countries. COVAX is a vaccine-sharing program of WHO. This program has forecasted that an additional 1.1 billion covid jabs will be made available on a global scale between now and later the year. These numbers are less than what WHO has previously hoped for.
The science is clear: "Booster doses for the general population are not appropriate at this stage in the pandemic.” Too many vulnerable people have not received their first dose. They must be the priority to avoid prolonging the pandemic and leaving people at risk. https://t.co/FZrTfTms5r
— Seth Berkley (@GaviSeth) September 14, 2021
92 lower-income countries are the target of vaccine supply for the remaining year. We expect to have a further 1.1 billion doses available for delivery between now and the end of the year," Dr. Seth Berkley, CEO of GAVI, one of the groups that make up COVAX, said in a media briefing.
This prediction will put the total availability of vaccines in 2021 at 1.4 billion doses. This is 1.2 billion less than what was hoped for in low-income countries.
That is why the rich countries are said to halt the availability of booster shots until the low-income countries have a significant number of inoculated masses.